AU Patent

AU2015276321B2 — Stable formulations of testosterone undecanoate

Assigned to Merck Sharp and Dohme BV · Expires 2019-10-24 · 7y expired

What this patent protects

The present invention is directed to stable pharmaceutical formulations. More specifically, the present invention is directed to stable pharmaceutical formulations of testosterone undecanoate.

USPTO Abstract

The present invention is directed to stable pharmaceutical formulations. More specifically, the present invention is directed to stable pharmaceutical formulations of testosterone undecanoate.

Drugs covered by this patent

Patent Metadata

Patent number
AU2015276321B2
Jurisdiction
AU
Classification
—
Expires
2019-10-24
Drug substance claim
No
Drug product claim
No
Assignee
Merck Sharp and Dohme BV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.